Infrequent Illicit Methadone Use Among Stimulant-Using Patients in Methadone Maintenance Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study

REFERENCES

• Compton W M, Volkow N D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend 2006; 81: 103–107
   PubMed Web of Science ®Google Scholar
• Office of Applied Studies. Results from the 2005 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, Substance Abuse and Mental Health Services, Rockville, MD 2006
   Google Scholar
• National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998; 280: 1936–1943
   PubMed Web of Science ®Google Scholar
• Center for Substance Abuse Treatment. What Every Individual Needs to Know about Methadone Maintenance Treatment: Introduction to Methadone. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Rockville, Md 2006, DHHS Publication No. [SMA] 06-4123; NCADI Publication No. PHD1124
   Google Scholar
• Dole V P, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA. 1965; 193: 646–650
   PubMed Web of Science ®Google Scholar
• O'Connor P G. Methods of detoxification and their role in treating patients with opioid dependence. JAMA. 2005; 294: 961–963
   PubMed Web of Science ®Google Scholar
• Office of Applied Studies Web site. The DASIS report: Facilities providing methadone/LAAM treatment to clients with opiate addiction. Substance Abuse and Mental Health Services Administration, Rockville, Md., Available at: http://www.oas.samhsa.gov/2k2/methadoneTX/methadoneTX.htm Accessed July 3, 2007
   Google Scholar
• U.S. Food and Drug Administration Web site. Drug shortage: Drug to be discontinued. Letter from Roxane. Food and Drug Administration, Available at: http://www.fda.gov/cder/drug/shortages/orlaam.htm Accessed July 3, 2007
   Google Scholar
• Center for Substance Abuse Treatment Web site. About buprenorphine therapy. Substance Abuse and Mental Health Services Administration, Rockville, Md., Available at: http://www.buprenorphine.samhsa.gov/about.html Accessed July 3, 2007
   Google Scholar
• Center for Substance Abuse Treatment Web site, Available at: http://www.csdp.org/research/methadone.samhsa204.pdf Methadone-associated mortality: Report of a national assessment, May 8–9, 2003. CSAT Publication no. 28-03. 2004. Rockville, Md.: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration. Accessed July 3, 2007
   Google Scholar
• Cicero T J, Inciardi J A. Diversion and abuse of methadone prescribed for pain management. JAMA 2005; 293: 297–298
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration Web site. FDA public health advisory: Methadone use for pain control may result in death and life-threatening changes in breathing and heart beat, Available at: http://www.fda.gov/cder/drug/advisory/methadone.htm Accessed July 3, 2007
   Google Scholar
• Office of Applied Studies Web site. The DAWN report: Methadone-involved deaths in eight metropolitan areas: 1997–2001. Substance Abuse and Mental Health Services Administration, Rockville, Md., Available at: http://dawninfo.samhsa.gov/old_dawn/pubs_94_02/shortreports/files/DAWN_tdr_meth.pdf Accessed July 3, 2007
   Google Scholar
• Paulozzi L J. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health. 2006; 96: 1755–1757
   PubMed Web of Science ®Google Scholar
• Office of Applied Studies Web site. The New DAWN report: Opiate-related drug misuse deaths in six states: 2003. Substance Abuse and Mental Health Services Administration, Rockville, Md., Available at: http://dawninfo.samhsa.gov/files/TNDR06OpiateMisuse.htm Accessed July 3, 2007
   Google Scholar
• Paulozzi L J, Budnitz D S, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006; 15: 618–627
   PubMed Web of Science ®Google Scholar
• National Drug Intelligence Center Web site, Available at: http://www.usdoj.gov/ndic/pubs6/6292/index.htm Information bulletin: Methadone abuse increasing. Accessed July 3, 2007
   Google Scholar
• Available at: http://frwebgate.access.gpo.gov/cgi-in/getpage.cgi?dbname=2001_register&position=all&page=4098 Office of the Federal Register Web site. Fed Regist. Vol. 66, No. 11, Rules and Regulations. Take-home Regulation Page 4090-4098. Accessed August 21, 2007
   Google Scholar
• Joranson D E, Gilson A M. Drug crime is a source of abuse pain medications in the United States. J Pain Symptom Manage 2005; 30: 299–301
   PubMed Web of Science ®Google Scholar
• Vlahov D, O'Driscoll P, Mehta S H, et al. Risk factors for methadone outside treatment programs: Implications for HIV treatment among injection drug users. Addiction. 2007; 102: 771–777
   PubMed Web of Science ®Google Scholar
• Weppner R S, Stephens R C, Conrad H T. Methadone: Some aspects of its legal and illegal use. Am J Psychiatry. 1972; 129: 451–455
   PubMed Web of Science ®Google Scholar
• Peirce J M, Petry N M, Stitzer M L, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2006; 63: 201–208
   PubMed Web of Science ®Google Scholar
• Scherbaum N, Kluwig J, Meiering C, Gastpar M. Use of illegally acquired medical opioids by opiate-dependent patients in detoxification treatment. Eur Addict Res. 2005; 11: 193–196
   Google Scholar
• Available at: http://www.nida.nih.gov/CTN/ National Institute on Drug Abuse Web site. National Drug Abuse Treatment Clinical Trials Network (CTN). Accessed March 20, 2007
   Google Scholar
• Available at: http://www.ctndatashare.org/ National Institute on Drug Abuse Web site. National Drug Abuse Treatment Clinical Trials Network: CTN Public Data Share. Accessed March 20, 2007
   Google Scholar
• Forman R F, Svikis D, Montoya I D, Blaine J. Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 2004; 27: 1–8
   PubMed Web of Science ®Google Scholar
• Hudziak J J, Helzer J E, Wetzel M W, et al. The use of the DSM-III-R Checklist for initial diagnostic assessment. Compr Psychiatry 1993; 34: 375–383
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4^th ed. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Petry N M, Peirce J M, Stitzer M L, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005; 62: 1148–1156
   PubMed Web of Science ®Google Scholar
• Lauzon P, Vincelette J, Bruneau J, et al. Illicit use of methadone among i.v. drug users in Montreal. J Subst Abuse Treat 1994; 11: 457–461
   PubMed Web of Science ®Google Scholar
• Fountain J, Strang J, Gossop M, Farrell M, Griffiths P. Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction. 2000; 95: 393–406
   PubMed Web of Science ®Google Scholar
• Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: Five-year monitoring of trends from the Illicit Drug Reporting System. Drug Alcohol Rev. 2002; 21: 27–32
   PubMed Web of Science ®Google Scholar
• Humeniuk R, Ali R, McGregor C, Darke S. Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction. 2003; 98: 413–418
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Lenne M, Ritter A. Methadone injecting in Australia: A tale of two cities. Addiction 1999; 94: 1175–1178
   PubMed Web of Science ®Google Scholar
• Condelli W S, Fairbank J A, Dennis M L, Rachal J V. Cocaine use by clients in methadone programs: Significance, scope, and behavioral interventions. J Subst Abuse Treat. 1991; 8: 203–212
   PubMed Web of Science ®Google Scholar
• Farley D. New drug approval approach boosts fight against heroin addiction, Available at: http://www.fda.gov/bbs/topics/CONSUMER/CON0291c.html U.S. Food and Drug Administration Web site. Accessed July 3, 2007
   Google Scholar
• Grant B F, Stinson F S, Dawson D A, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61: 807–816
   PubMed Web of Science ®Google Scholar